Skip to main content
SpringerLink
Log in

Drugs for Thromboprophylaxis: Unfractionated Heparin, Low Molecular Weight Heparin, Warfarin, and Fondaparinux

  • Chapter
  • First Online:
Thromboembolism in Orthopedic Surgery

Abstract

The world of antithrombotic prophylaxis is a revolutionary phase due to the introduction of numerous new compounds in the daily practice. However, traditional antithrombotics are still in use. This chapter deals with advantages and disadvantages of the traditional drugs used in this context: unfractionated heparin, low molecular weight heparin, and fondaparinux. The use of these drugs will decrease, but specific indications will remain. This point will also be emphasized in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):188S–203.

    Article  PubMed  CAS  Google Scholar 

  2. Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, et al. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost. 2008;34(1):58–73.

    Article  PubMed  CAS  Google Scholar 

  3. Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Semin Thromb Hemost. 2008;34(1):39–57.

    Article  PubMed  CAS  Google Scholar 

  4. Mannucci PM, Poller L. Venous thrombosis and anticoagulant therapy. Br J Haematol. 2001;114(2):258–70.

    Article  PubMed  CAS  Google Scholar 

  5. Rosencher N, Bonnet MP, Sessler DI. Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies. Anaesthesia. 2007;62(11):1154–60.

    Article  PubMed  CAS  Google Scholar 

  6. Geerts WH. Prevention of venous thromboembolism in high-risk patients. Hematology Am Soc Hematol Educ Program. 2006:462–6.

    Google Scholar 

  7. Kurmis AP. Review article: thromboprophylaxis after total hip replacement. J Orthop Surg (Hong Kong). 2010;18(1):92–7.

    Google Scholar 

  8. Choi BY, Huo MH. Venous thromboembolism following total knee replacement. J Surg Orthop Adv. 2007;16(1):31–5.

    PubMed  Google Scholar 

  9. Rogers BA, Little NJ. Thromboprophylaxis in orthopaedic surgery: a clinical review. J Perioper Pract. 2010;20(10):358–62.

    PubMed  Google Scholar 

  10. Abad Rico JI, Llau Pitarch JV, Rocha E. Overview of venous thromboembolism. Drugs. 2010;70 Suppl 2:3–10.

    Article  PubMed  Google Scholar 

  11. Duggan ST, Scott LJ, Plosker GL. Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery. Drugs. 2009;69(13):1829–51.

    Article  PubMed  CAS  Google Scholar 

  12. Bergqvist D. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery. Vasc Health Risk Manag. 2006;2(4):365–70.

    Article  PubMed  CAS  Google Scholar 

  13. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med. 2003;28(3):172–97.

    PubMed  Google Scholar 

  14. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK. Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of regional anesthesia and pain medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35(1):102–5.

    Article  PubMed  Google Scholar 

  15. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of regional anesthesia and pain medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35(1):64–101.

    Article  PubMed  CAS  Google Scholar 

  16. Gogarten W. The influence of new antithrombotic drugs on regional anesthesia. Curr Opin Anaesthesiol. 2006;19(5):545–50.

    Article  PubMed  Google Scholar 

  17. Haas S, Schellong S. New anticoagulants: from bench to bedside. Hamostaseologie. 2007;27(1):41–7.

    PubMed  CAS  Google Scholar 

  18. Harbrecht U. Old and new anticoagulants. Hamostaseologie. 2011;31(1):21–7.

    Article  PubMed  CAS  Google Scholar 

  19. Levy JH, Key NS, Azran MS. Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology. 2010;113(3):726–45.

    PubMed  CAS  Google Scholar 

  20. Hong MS, Amanullah AM. Heparin-induced thrombocytopenia: a practical review. Rev Cardiovasc Med. 2010;11(1):13–25.

    PubMed  Google Scholar 

  21. Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol. 2010;24(1):27–40.

    Article  PubMed  Google Scholar 

  22. Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):141S–59.

    Article  PubMed  CAS  Google Scholar 

  23. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997;337(10):688–98.

    Article  PubMed  CAS  Google Scholar 

  24. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):160S–98.

    Article  PubMed  CAS  Google Scholar 

  25. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492–501.

    PubMed  CAS  Google Scholar 

  26. Haas S. Medical indications and considerations for future clinical decision making. Thromb Res. 2003;109 Suppl 1:S31–7.

    Article  PubMed  CAS  Google Scholar 

  27. Eriksson BI, Quinlan DJ. Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery. Drugs. 2006;66(11):1411–29.

    Article  PubMed  CAS  Google Scholar 

  28. Levy JH, Tanaka KA, Dietrich W. Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology. 2008;109(5):918–26.

    Article  PubMed  CAS  Google Scholar 

  29. West KL, Adamson C, Hoffman M. Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature. J Neurosurg. 2011;114(1):9–18.

    Article  PubMed  Google Scholar 

  30. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162(16):1833–40.

    Article  PubMed  CAS  Google Scholar 

  31. Blick SK, Orman JS, Wagstaff AJ, Scott LJ. Fondaparinux sodium: a review of its use in the management of acute coronary syndromes. Am J Cardiovasc Drugs. 2008;8(2):113–25.

    PubMed  CAS  Google Scholar 

  32. Turpie AG, Eriksson BI, Lassen MR, Bauer KA. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. J South Orthop Assoc. 2002;11(4):182–8.

    PubMed  Google Scholar 

  33. Lisman T, Bijsterveld NR, Adelmeijer J, Meijers JC, Levi M, Nieuwenhuis HK, et al. Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux. J Thromb Haemost. 2003;1(11):2368–73.

    Article  PubMed  CAS  Google Scholar 

  34. Giangrande PL. Fondaparinux (arixtra): a new anticoagulant. Int J Clin Pract. 2002;56(8):615–7.

    PubMed  CAS  Google Scholar 

  35. Bauer KA. Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm. 2001;58 Suppl 2:S14–7.

    PubMed  CAS  Google Scholar 

  36. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med. 2004;140(11):867–73.

    PubMed  Google Scholar 

  37. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349(18):1695–702.

    Article  PubMed  CAS  Google Scholar 

  38. Singelyn FJ, Verheyen CC, Piovella F, Van Aken HK, Rosencher N. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study. Anesth Analg. 2007;105(6):1540–7. table of contents.

    Article  PubMed  CAS  Google Scholar 

  39. Bates SM, Weitz JI. New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin. Br J Pharmacol. 2005;144(8):1017–28.

    Article  PubMed  CAS  Google Scholar 

  40. Petitou M, Duchaussoy P, Herbert JM, Duc G, El Hajji M, Branellec JF, et al. The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa. Semin Thromb Hemost. 2002;28(4):393–402.

    Article  PubMed  CAS  Google Scholar 

  41. Bauer KA, Hawkins DW, Peters PC, Petitou M, Herbert JM, van Boeckel CA, et al. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. Cardiovasc Drug Rev. 2002;20(1):37–52.

    Article  PubMed  CAS  Google Scholar 

  42. Hirsh J, O’Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation. 2007;116(5):552–60.

    Article  PubMed  CAS  Google Scholar 

  43. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):311S–37.

    Article  PubMed  CAS  Google Scholar 

  44. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):338S–400.

    Article  PubMed  CAS  Google Scholar 

  45. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):401S–28.

    Article  PubMed  CAS  Google Scholar 

  46. Agrawal YK, Vaidya H, Bhatt H, Manna K, Brahmkshatriya P. Recent advances in the treatment of thromboembolic diseases: venous thromboembolism. Med Res Rev. 2007;27(6):891–914.

    Article  PubMed  CAS  Google Scholar 

  47. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):429S–56.

    Article  PubMed  CAS  Google Scholar 

  48. Marcucci M, Iorio A, Nobili A, Tettamanti M, Pasina L, Marengoni A, et al. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Intern Med. 2010;21(6):516–23.

    Article  PubMed  CAS  Google Scholar 

  49. Braun S, Voller H, Soppa C, Taborski U. Update of guidelines for patient self-management of oral anticoagulation. Dtsch Med Wochenschr. 2009;134(14):695–700.

    Article  PubMed  CAS  Google Scholar 

  50. Harrington RA, Becker RC, Ezekowitz M, Meade TW, O’Connor CM, Vorchheimer DA, et al. Antithrombotic therapy for coronary artery disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):513S–48.

    Article  PubMed  CAS  Google Scholar 

  51. Menon V, Harrington RA, Hochman JS, Cannon CP, Goodman SD, Wilcox RG, et al. Thrombolysis and adjunctive therapy in acute myocardial infarction: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):549S–75.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of Interest

None.

Author information

Authors and Affiliations

  1. Division of Anesthesiology, Balgrist University Hospital, Forchstrasse 340, 8008, Zürich, Switzerland

    José Aguirre M.D. & Alain Borgeat M.D.

Authors
  1. José Aguirre M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alain Borgeat M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alain Borgeat M.D. .

Editor information

Editors and Affiliations

  1. , Department of Anaesthesiology and Critic, University Hospital of Valencia, Valencia, 46010, Spain

    Juan V. Llau

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Aguirre, J., Borgeat, A. (2013). Drugs for Thromboprophylaxis: Unfractionated Heparin, Low Molecular Weight Heparin, Warfarin, and Fondaparinux. In: Llau, J. (eds) Thromboembolism in Orthopedic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4336-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4336-9_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4335-2

  • Online ISBN: 978-1-4471-4336-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation